TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy
Background Transforming growth factor-beta (TGFβ) can limit the efficacy of cancer treatments, including radiotherapy (RT), by inducing an immunosuppressive tumor environment. The association of TGFβ with impaired T cell infiltration and antitumor immunity is known, but the mechanisms by which TGFβ...
Saved in:
| Main Authors: | Eric Deutsch, Michele Mondini, Nicolas Signolle, Pauline Hamon, Marine Gerbé De Thoré, Marion Classe, Winchygn Liu, Olivia Bawa, Lydia Meziani, Céline Clémenson, Fabien Milliat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/3/e003519.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
by: Eric Deutsch, et al.
Published: (2020-05-01) -
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect
by: Pierre-Antoine Laurent, et al.
Published: (2025-06-01) -
Heterogeneous intratumor irradiation: a new partner for immunotherapy
by: Paul Bergeron, et al.
Published: (2024-12-01) -
Regulation of TGF-β Signal Transduction
by: Bing Zhao, et al.
Published: (2014-01-01) -
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
by: Candice Sakref, et al.
Published: (2025-03-01)